America February 12, 2024
Gilead To Buy CymaBay For $4.3B : A Liver Health Power Play
In a bold move poised to reshape the landscape of liver disease treatment, Gilead Sciences Inc. has announced its acquisition…
America February 12, 2024
In a bold move poised to reshape the landscape of liver disease treatment, Gilead Sciences Inc. has announced its acquisition…
By Rihem Akkouche
America January 17, 2024
In a strategic financial move, pharmaceutical powerhouse GSK (formerly GlaxoSmithKline) announced on Wednesday that it has successfully divested a significant…
By Rihem Akkouche
America January 9, 2024
In a bold move to bolster its respiratory treatments arsenal, GSK PLC, the British pharmaceutical giant, announced a groundbreaking deal…
By Rihem Akkouche
America August 29, 2023
In a significant move bound to ripple through the healthcare landscape, the U.S. Department of Health and Human Services (HHS)…
By Rihem Akkouche
Business October 5, 2020
Bristol Myers Squibb (NYSE: BMY) announced that it will buy MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion or $225 per…
By Sean Corliss